跳至主要内容
临床试验/NCT01963741
NCT01963741已完成不适用

Leukotriene D4 Nasal Provocation Test: Rationale, Methodology, Diagnostic Value and Its Impact on Airway Inflammation in Allergic Rhinitis With or Without Asthma

Guangzhou Institute of Respiratory Disease1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2012年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60
试验地点
1
主要终点
Percentage of participants positive response to leukotriene D4 or histamine nasal provocation test

研究概览

简要总结

Leukotrienes play critical roles in the inflammatory process in allergic rhinitis and bronchial asthma, therefore, anti-leukotriene therapy is part of treatment for asthma. However, not all allergic rhinitis accompanied with or without asthma treated with anti-leukotriene were effective. So it is critical to develop a method to identify the response subgroup. In this study, it is assumed that nasal physiological responsiveness to leukotriene nasal provocation test (NPT) is able to gain evidence on the effect of leukotriene on the development of allergic rhinitis and asthma, and is helpful to the use of anti-leukotriene agent. The purpose of the study is to establish the methodology and diagnostic value of leukotriene D4 (LTD4) nasal provocation.

详细描述

Nasal provocation test induced by LTD4 will be conducted by measuring nasal airway resistance and airway symptoms in a stepwise concentration of LTD4 by nasal spray. Inflammation biomarkers, such as eosinophilic granulocyte in sputum and nasal lavage, fractional exhaled nitric oxide(FeNO), and lung function before and after nasal provocation will be studied to explore the impact of LTD4 nasal provocation test on airway inflammation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Diagnostic
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with allergic rhinitis accompanied with or without asthma
  • positive skin prick test (SPT)
  • had no acute upper or lower airway infection 2 weeks prior to study
  • no oral or nasal anti-histamines
  • no leukotriene receptor antagonists for 1 week
  • no oral or nasal and inhaled corticosteroids for 2 weeks

排除标准

  • a past confirmed history of chronic respiratory disease other than asthma
  • other severe systemic diseases (myocardial infarction, malignant tumor, etc.)
  • under immunotherapy
  • unable to complete the test or had limited understanding
  • pregnancy

研究组 & 干预措施

leukotriene D4

Experimental

Nasal provocation test was induced by leukotriene D4 with a stepwisely concentration method (4 mcg/ml, 8 mcg/ml, 16 mcg/ml).

干预措施: histamine (Drug)

histamine

Experimental

Nasal provocation test was induced by histamine with a stepwisely concentration method (0.4 mg/ml, 0.8 mg/ml, 1.6 mg/ml, 3.2mg/ml).

干预措施: leukotriene D4 (Drug)

结局指标

主要结局

Percentage of participants positive response to leukotriene D4 or histamine nasal provocation test

时间窗: Until 1 hour after the nasal provocation test

Nasal airway resistance measured by positive anterior rhinomanometry. Concentration induced 60% increase of nasal airway resistance (PC60-NAR) will be measured and reported; Composite symptoms score defined by reichmann H and his colleagues showed as follows:3-5 sneezes = 1 point (pt), \>5 sneezes = 2 points (pts); rhinorrhoea \< 1 milliliter (mL) = 1 pt, rhinorrhoea \> 1 milliliter = 2 pts; pruritus of the palate or ear or eye= 1 pt, conjunctivitis or cough or urticaria or difficult breathing= 2 pts. Total score ranges from 0 to 6 pts. Positive response to LTD4 nasal provocation test was defined as PC60-NAR less than 16mcg/mL or the symptom score higher than 3.

次要结局

  • Change from baseline of eosinophils in sputum and nasal lavage and fractional exhaled nitric oxide (FeNO)(4 and 24 hours after the nasal provocation test)

研究者

发起方
Guangzhou Institute of Respiratory Disease
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jinping Zheng

Professor,Guangzhou institute of respiratory disease

The First Affiliated Hospital of Guangzhou Medical University

研究点 (1)

Loading locations...

相似试验

Leukotriene D4 Nasal Provocation Test in Allergic... | 临床试验